The application concerns a compound of formula I: ##STR1##

wherein one of P and Q is O, and the other of P and Q is CH, where there is a double bond between whichever of Q and P is CH and the carbon atom bearing the R3 group;

    • Y is either O or S;
    • R1 and R2 are independently hydrogen, an optionally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form an optionally substituted heterocyclic ring having from 4 to 8 ring atoms;
    • R3 is a phenyl or pyridyl group, attached by a first bridge group selected from —S—, —S(O)—, —S(O)2—, —O—, —NRN— and CRC1RC2— to an optionally substituted C5-20 carboaryl group, the phenyl or pyridyl group and optionally substituted C5-20 carboaryl group being optionally further linked by a second bridge group, so as to form an optionally substituted C5-7 ring, the phenyl or pyridyl group being further optionally substituted.
  •  
    Web www.patentalert.com

    < Glucagon-like peptide-2 and its therapeutic use

    < Compositions of CPG and saponin adjuvants and uses thereof

    > Substituted heterocyclic compounds and methods of use

    > HIV inhibiting N-aminoimidazole derivatives

    ~ 00263